The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pentazocine-Global Market Insights and Sales Trends 2024
Synopsis
Pentazocine, sold under the brand name Talwin among others, is a painkiller used to treat moderate to severe pain. It is believed to work by activating (agonizing) κ-opioid receptors (KOR) and blocking (antagonizing) μ-opioid receptors (MOR). As such it is called an opioid as it delivers its effects on pain by interacting with the opioid receptors. It shares many of the side effects of other opioids like constipation, nausea, itching, drowsiness and a reduced effort to breathe, but unlike most other opioids it fairly frequently causes hallucinations, nightmares and delusions. It is also, unlike most other opioids, subject to a ceiling effect, which is when at a certain dose (which differs from person-to-person) no more pain relief, or side effects, is obtained by increasing the dose any further.
The global Pentazocine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pentazocine in various end use industries. The expanding demands from the Adults, Children and Elderly,, are propelling Pentazocine market. Injections, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Pentazocine market, driven by demand from China, the second largest economy with some signs of stabilising, the Pentazocine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pentazocine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pentazocine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pentazocine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pentazocine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pentazocine covered in this report include Teva, pfizer, Merck KGaA and LUPIN PHARMACEUTICALS, etc.
The global Pentazocine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
pfizer
Merck KGaA
LUPIN PHARMACEUTICALS
Global Pentazocine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pentazocine market, Segment by Type:
Injections
Tablets
Global Pentazocine market, by Application
Adults
Children
Elderly
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pentazocine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pentazocine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Pentazocine, sold under the brand name Talwin among others, is a painkiller used to treat moderate to severe pain. It is believed to work by activating (agonizing) κ-opioid receptors (KOR) and blocking (antagonizing) μ-opioid receptors (MOR). As such it is called an opioid as it delivers its effects on pain by interacting with the opioid receptors. It shares many of the side effects of other opioids like constipation, nausea, itching, drowsiness and a reduced effort to breathe, but unlike most other opioids it fairly frequently causes hallucinations, nightmares and delusions. It is also, unlike most other opioids, subject to a ceiling effect, which is when at a certain dose (which differs from person-to-person) no more pain relief, or side effects, is obtained by increasing the dose any further.
The global Pentazocine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pentazocine in various end use industries. The expanding demands from the Adults, Children and Elderly,, are propelling Pentazocine market. Injections, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Pentazocine market, driven by demand from China, the second largest economy with some signs of stabilising, the Pentazocine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pentazocine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pentazocine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pentazocine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pentazocine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pentazocine covered in this report include Teva, pfizer, Merck KGaA and LUPIN PHARMACEUTICALS, etc.
The global Pentazocine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
pfizer
Merck KGaA
LUPIN PHARMACEUTICALS
Global Pentazocine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pentazocine market, Segment by Type:
Injections
Tablets
Global Pentazocine market, by Application
Adults
Children
Elderly
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pentazocine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pentazocine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pentazocine Market Overview
1.1 Pentazocine Product Overview
1.2 Pentazocine Market Segment by Type
1.2.1 Injections
1.2.2 Tablets
1.3 Global Pentazocine Market Size by Type
1.3.1 Global Pentazocine Market Size Overview by Type (2018-2029)
1.3.2 Global Pentazocine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pentazocine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pentazocine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pentazocine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pentazocine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pentazocine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pentazocine Sales Breakdown by Type (2018-2023)
2 Global Pentazocine Market Competition by Company
2.1 Global Top Players by Pentazocine Sales (2018-2023)
2.2 Global Top Players by Pentazocine Revenue (2018-2023)
2.3 Global Top Players by Pentazocine Price (2018-2023)
2.4 Global Top Manufacturers Pentazocine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pentazocine Market Competitive Situation and Trends
2.5.1 Pentazocine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pentazocine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pentazocine as of 2022)
2.7 Date of Key Manufacturers Enter into Pentazocine Market
2.8 Key Manufacturers Pentazocine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pentazocine Status and Outlook by Region
3.1 Global Pentazocine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pentazocine Historic Market Size by Region
3.2.1 Global Pentazocine Sales in Volume by Region (2018-2023)
3.2.2 Global Pentazocine Sales in Value by Region (2018-2023)
3.2.3 Global Pentazocine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pentazocine Forecasted Market Size by Region
3.3.1 Global Pentazocine Sales in Volume by Region (2024-2029)
3.3.2 Global Pentazocine Sales in Value by Region (2024-2029)
3.3.3 Global Pentazocine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pentazocine by Application
4.1 Pentazocine Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.1.3 Elderly
4.2 Global Pentazocine Market Size by Application
4.2.1 Global Pentazocine Market Size Overview by Application (2018-2029)
4.2.2 Global Pentazocine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pentazocine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pentazocine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pentazocine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pentazocine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pentazocine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pentazocine Sales Breakdown by Application (2018-2023)
5 North America Pentazocine by Country
5.1 North America Pentazocine Historic Market Size by Country
5.1.1 North America Pentazocine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pentazocine Sales in Volume by Country (2018-2023)
5.1.3 North America Pentazocine Sales in Value by Country (2018-2023)
5.2 North America Pentazocine Forecasted Market Size by Country
5.2.1 North America Pentazocine Sales in Volume by Country (2024-2029)
5.2.2 North America Pentazocine Sales in Value by Country (2024-2029)
6 Europe Pentazocine by Country
6.1 Europe Pentazocine Historic Market Size by Country
6.1.1 Europe Pentazocine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pentazocine Sales in Volume by Country (2018-2023)
6.1.3 Europe Pentazocine Sales in Value by Country (2018-2023)
6.2 Europe Pentazocine Forecasted Market Size by Country
6.2.1 Europe Pentazocine Sales in Volume by Country (2024-2029)
6.2.2 Europe Pentazocine Sales in Value by Country (2024-2029)
7 Asia-Pacific Pentazocine by Region
7.1 Asia-Pacific Pentazocine Historic Market Size by Region
7.1.1 Asia-Pacific Pentazocine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pentazocine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pentazocine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pentazocine Forecasted Market Size by Region
7.2.1 Asia-Pacific Pentazocine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pentazocine Sales in Value by Region (2024-2029)
8 Latin America Pentazocine by Country
8.1 Latin America Pentazocine Historic Market Size by Country
8.1.1 Latin America Pentazocine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pentazocine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pentazocine Sales in Value by Country (2018-2023)
8.2 Latin America Pentazocine Forecasted Market Size by Country
8.2.1 Latin America Pentazocine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pentazocine Sales in Value by Country (2024-2029)
9 Middle East and Africa Pentazocine by Country
9.1 Middle East and Africa Pentazocine Historic Market Size by Country
9.1.1 Middle East and Africa Pentazocine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pentazocine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pentazocine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pentazocine Forecasted Market Size by Country
9.2.1 Middle East and Africa Pentazocine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pentazocine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Pentazocine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Pentazocine Products Offered
10.1.5 Teva Recent Development
10.2 pfizer
10.2.1 pfizer Company Information
10.2.2 pfizer Introduction and Business Overview
10.2.3 pfizer Pentazocine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 pfizer Pentazocine Products Offered
10.2.5 pfizer Recent Development
10.3 Merck KGaA
10.3.1 Merck KGaA Company Information
10.3.2 Merck KGaA Introduction and Business Overview
10.3.3 Merck KGaA Pentazocine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck KGaA Pentazocine Products Offered
10.3.5 Merck KGaA Recent Development
10.4 LUPIN PHARMACEUTICALS
10.4.1 LUPIN PHARMACEUTICALS Company Information
10.4.2 LUPIN PHARMACEUTICALS Introduction and Business Overview
10.4.3 LUPIN PHARMACEUTICALS Pentazocine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LUPIN PHARMACEUTICALS Pentazocine Products Offered
10.4.5 LUPIN PHARMACEUTICALS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pentazocine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pentazocine Industrial Chain Analysis
11.4 Pentazocine Market Dynamics
11.4.1 Pentazocine Industry Trends
11.4.2 Pentazocine Market Drivers
11.4.3 Pentazocine Market Challenges
11.4.4 Pentazocine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pentazocine Distributors
12.3 Pentazocine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
